oppalerts.com →
Industry Report

Weight Loss Clinics GLP-1 Telehealth

Knowledge Graph Entities
Strong · SE Outbound Links ρ=0.262

AI recommendation signal analysis across 2,549 domains and 11 buyer personas in Weight Loss Clinics GLP-1 Telehealth, led by ro.co as the most LLM-recommended domain.

2,549Domains Tracked
11Buyer Personas
53.5MReddit Posts
91KWikipedia Articles
32.2MOpen Web Matches
knowledge_graph_entities.report
EntityScore
Juniper (telehealth company)
92.1
Trimi Health
70.9
Lemon8
60.0
Journal of Occupational Therapy, Schools and Early Intervention: innovations in practice, theory, and research
56.2
Cora Health
56.2
Want a custom AI visibility audit for Weight Loss Clinics GLP-1 Telehealth?

This report tracks how AI models and search engines recommend companies across 100 industries. If you want the same analysis run specifically against your own site and competitors, get in touch.

Get in touch
About This Report

How to use this page

Industry view: this page aggregates every persona's data for the whole industry, plus industry-wide queries. Pick a persona from the sidebar to narrow the lens to one segment.
Use Case

Check your knowledge-graph footprint

Wikidata is the structured knowledge graph behind Wikipedia, search engines, and many AI systems. If the graph does not know a brand, machines have less to anchor an answer on. See which entities carry this segment's topics and brands, and whether its top domains have an entity at all.

How It's Calculated

Where the numbers come from

We scan every Wikidata entity record (labels, descriptions, property values) for this segment's topic phrases and brand hostnames. Entity records are short structured data, so counts run far smaller than article text. Coverage checks which entities claim each domain as an official website.

Overview

What's on this page

Top-entity charts, the full entity table, and a knowledge-graph coverage check for this segment's most LLM-recommended domains.

Segment Totals

Knowledge graph at a glance

How much of the Wikidata knowledge graph touches Weight Loss Clinics GLP-1 Telehealth across all personas. Entity records are short structured data (labels, descriptions, property values), so these counts run far smaller than Wikipedia article text; what matters is which entities show up, not raw volume.

252K
Entities With Topic Matches
35K
Entities Mentioning Brands
265K
Topic Phrase Matches
37K
Brand Mentions
Top Domains

Knowledge graph coverage

Whether a Wikidata entity claims each of this segment's most LLM-recommended domains as its official website. A brand without an entity is invisible to systems that navigate the web through the knowledge graph.

6 of 25 top domains for Weight Loss Clinics GLP-1 Telehealth have a knowledge-graph entity.

DomainKnowledge Graph EntityWikidata ID
ro.coRomanQ48743480
joinmochi.comNot in the knowledge graph-
formhealth.coNot in the knowledge graph-
found.comNot in the knowledge graph-
weightwatchers.comWW InternationalQ1929466
plushcare.comPlushCareQ106752047
calibrate.comNot in the knowledge graph-
joinfound.comNot in the knowledge graph-
joinsequence.comNot in the knowledge graph-
sequence.comNot in the knowledge graph-
foundhealth.comNot in the knowledge graph-
noom.comNoom (United States)Q64142219
henrymeds.comNot in the knowledge graph-
joinmidi.comNot in the knowledge graph-
sesamecare.comSesameQ107974738
allarahealth.comNot in the knowledge graph-
mochihealth.comNot in the knowledge graph-
knownwell.coNot in the knowledge graph-
midihealth.comNot in the knowledge graph-
joincalibrate.comNot in the knowledge graph-
hims.comNot in the knowledge graph-
virtahealth.comVirta HealthQ98609603
hers.comNot in the knowledge graph-
mavenclinic.comNot in the knowledge graph-
sequencehealth.comNot in the knowledge graph-
Wikidata

Top knowledge-graph entities

The entity records where Weight Loss Clinics GLP-1 Telehealth's brands and topics appear, aggregated across all personas. Brand Mentions is the more reliable single ranking here; broadly used phrases can surface large unrelated entities in the topic view. Blended merges the two on a log scale (brand mentions weighted higher, 0 to 100). Bars and entity names link to the record; entities with no label show their Wikidata ID. The table follows the selected view.


EntityBlendedBrand MentionsTopic Matches
Juniper (telehealth company)92.164
Trimi Health70.933
Lemon860.070
Journal of Occupational Therapy, Schools and Early Intervention: innovations in practice, theory, and research56.222
Cora Health56.222
WeightlessRx56.222
Information Retrieval56.160
Inflammopharmacology56.160
Complex Metals: An Open Access Journal56.160
Single Set Strength Training Increases Strength, Endurance and Functional Fitness in Community Living Older Adults55.531
Regional Studies, Regional Science51.750
Territory, Politics, Governance51.750
Journal of Environmental Economics and Policy51.750
Chronic Disease Prevention and Health Promotion47.221
Effectiveness of a school-based early intervention CBT group programme for children with anxiety aged 5–7 years47.221
Pilot evaluation of the feasibility and acceptability of StressOFF Strategies: a single-session school-based stress management program for adolescents47.221
Lifesum47.221
Bulletin of the Atomic Scientists46.440
Mayo Clinic46.440
British Poultry Science46.440
Frontiers in Life Science: frontiers of interdisciplinary research in the life sciences46.440
Slavery & Abolition46.440
Cleveland Clinic46.440
Continuum: Journal of Media & Cultural Studies46.440
RUSI Journal46.440
Trends in Amplification46.440
Rice46.440
Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare46.440
Amino Acids46.440
Public Library Quarterly46.440
Climate and Development46.440
Human Vaccines & Immunotherapeutics46.440
Dermato-endocrinology46.440
Prion46.440
Worm46.440
Translation (Austin, Tex.)46.440
Community Health Network46.440
Journal of Enterprise Transformation46.440
Ascension46.440
Putting the Diabetes Prevention Program into practice: a program for weight loss and cardiovascular risk reduction for patients with metabolic syndrome or type 2 diabetes mellitus40.005
Michael Miller40.005
National Institute for Occupational Safety and Health40.030
Q22988340.030
United States National Institutes of Health40.030
American Medical Association40.030
Runner's World40.030
Cryptologia40.030
Autophagy40.030
Communications in Soil Science and Plant Analysis40.030
Animal Biotechnology40.030
Quantitative Infra Red Thermography Journal40.030
Cancer Biology and Therapy40.030
American Mathematical Monthly40.030
Quarterly Journal of Experimental Psychology40.030
Journal of Applied Animal Research40.030
Synthetic Communications40.030
Imago Mundi40.030
Journal of the American Statistical Association40.030
Algebra Universalis40.030
American Journal of Sexuality Education40.030
Dance Chronicle40.030
Israel Journal of Foreign Affairs40.030
Journal of Contemporary China40.030
Journal of Library Administration40.030
Labor History40.030
Monoclonal Antibodies40.030
Mediterranean Historical Review40.030
Nordic Journal for Masculinity Studies40.030
Psychological Reports40.030
Quality Engineering40.030
RNA Biology40.030
Social Movement Studies40.030
The Professional Geographer40.030
Urban Geography40.030
The AAPS Journal40.030
The American Statistician40.030
Stochastics40.030
Transport Theory and Statistical Physics40.030
Aequationes Mathematicae40.030
International Journal of Biodiversity Science, Ecosystem Services & Management40.030
Journal of Carbohydrate Chemistry40.030
Journal of Essential Oil Research40.030
Porn Studies40.030
Tissue Barriers40.030
Small GTPases (journal)40.030
Oxford Development Studies40.030
Food Additives And Contaminants Part B: Surveillance Communications40.030
Journal of Youth Studies40.030
Spatial Economic Analysis40.030
American Journalism40.030
Analytical Letters40.030
Arboricultural Journal40.030
Journal of Applied Statistics40.030
Communications in Statistics: Simulation and Computation40.030
Health Care for Women International40.030
British Journal of Biomedical Science40.030
Studies on Neotropical Fauna and Environment40.030
Scandinavian Journal of History40.030
International Review of Psychiatry40.030
Life Writing40.030
History of Photography40.030
Epigenetics40.030
Canadian Slavonic Papers40.030
Hum Vaccin40.030
Journal of Iberian and Latin American Studies40.030
Journal of Risk Research40.030
Journal of Immunoassay and Immunochemistry40.030
Journal of Architectural Conservation40.030
Language and Cognitive Processes40.030
New Zealand Entomologist40.030
Baltic Journal of Economics40.030
Australian Forestry40.030
Romance Quarterly40.030
Citizenship Studies40.030
Journal of Information Technology Case and Application Research40.030
Physical Geography40.030
Psychiatry40.030
Intelligence and National Security40.030
South African Historical Journal40.030
International Journal of Sport and Exercise Psychology40.030
Music Reference Services Quarterly40.030
British Journal of Middle Eastern Studies40.030
International Journal of Modelling and Simulation40.030
Neural Development40.030
Organogenesis40.030
Social Dynamics40.030
Global Public Health40.030
Word and Image40.030
The Review of Black Political Economy40.030
Channels40.030
Youth Theatre Journal40.030
Journal of Biopharmaceutical Statistics40.030
Visual Resources40.030
Journal of Divorce and Remarriage40.030
Women's History Review40.030
Cold War History40.030
Visual Culture in Britain40.030
American Journal of Managed Care40.030
Parenting: Science and Practice40.030
South Asian History and Culture40.030
Journal of Graphic Novels and Comics40.030
Journal of Electronic Resources in Medical Libraries40.030
Journal of Family Psychotherapy40.030
Cell Adhesion and Migration40.030
Journal of Social Work Practice in the Addictions40.030
Mycology40.030
Annals of GIS40.030
Medical Reference Services Quarterly40.030
OncoImmunology40.030
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration40.030
Cellular logistics40.030
Biomatter40.030
Spermatogenesis40.030
JAK-STAT40.030
Bioengineered40.030
Libyan journal of medicine40.030
Vital and health statistics. Series 21, Data on natality, marriage, and divorce40.030
Vital and health statistics. Series 5, Comparative international vital and health statistics reports40.030
Applied neuropsychology. Adult40.030
Advances in eating disorders (Abingdon, England )40.030
Applied neuropsychology. Child40.030
Computer methods in biomechanics and biomedical engineering. Imaging & visualization40.030
Rare diseases (Austin, Tex.)40.030
Journal of sport psychology in action40.030
Migration and development40.030
Perspectives on political science40.030
Carl T. Hayden Veterans Affairs Medical Center40.030
Church, Communication and Culture40.030
Monograph of the Palaeontographical Society40.030
Journal of Computational and Theoretical Transport40.030
Journal of Global Scholars of Marketing Science40.030
Russian Journal of Communication40.030
Global Discourse40.030
Journal of Responsible Innovation40.030
Cricket and Community in England: 1800 to the Present Day40.030
Towards World Heritage: International Origins of the Preservation Movement, 1870–193040.030
Clinical Trials Cannot Substitute for Health System Strengthening Initiatives or Specifically Designed Health Policy and Systems Research40.030
Inspired Translation: Synthesizing Qualitative Research and Boot Camp Translation to Achieve Meaningful Community Engagement40.030
Scriptless Connection of Sensor Data Processing Components in Network Middleware for Home Environment40.030
Development of an In Situ Thermal Desorption Gas Chromatography Instrument for Quantifying Atmospheric Semi-Volatile Organic Compounds40.030
CyberEx Internet-Based Group Exercise for Rural Older Adults: A Pilot Study40.030
Feasibility and impact of implementing motivational enhancement therapy–cognitive behavioral therapy as a substance use treatment intervention in school-based settings40.030
Exploring a Mindfulness Meditation Program on the Mental Health of Upper Primary Children: A Pilot Study40.030
Unpacking Interdisciplinary Collaboration in Expanded School Mental Health: A Conceptual Model for Developing the Evidence Base40.030
Functional Fitness Testing of Older Adults: An Intergenerational Service Learning Experience40.030
Mental Health Issues of Older Women: A Comprehensive Review for Health Care Professionals, edited by Victor J. Malatesta40.030
“To Form a More Perfect Union”: How a University and a Public School District Collaborated to Create a Field-Based Masters Degree Program in Elementary Education40.030
African Journalism Studies40.030
Peacebuilding40.030
Journal of Trust Research40.030
Méthod(e)s African Review of Social Sciences Methodology40.030
Area Development and Policy40.030
Asia Pacific Translation and Intercultural Studies40.030
Canadian Art Therapy Association Journal40.030
Cities & Health40.030
Comedy Studies40.030
Counseling Outcome Research and Evaluation40.030
Critical Studies on Security40.030
Health Systems & Reform40.030
Papers in Applied Geography40.030
Studies in Eastern European Cinema40.030
Food economics : the official journal of the Nordic Association of Agricultural Scientists (NJF)40.030
Revue Europeenne des Elements40.030
Office of Readiness and Response40.030
Challenges and strategies in building a foundational digital health data integration ecosystem: a systematic review and thematic synthesis40.030
Clinical trial NCT0759738240.030
Clinical trial NCT0758582540.030
Clinical trial NCT0757161640.030
Clinical trial NCT0757162940.030
Clinical trial NCT0761103240.030
Obesity, central adiposity and cardiometabolic risk factors in children and adolescents: a family‐based study35.904
Metabolic Syndrome: Polycystic Ovary Syndrome35.904
A Lower-Carbohydrate, Higher-Fat Diet Reduces Abdominal and Intermuscular Fat and Increases Insulin Sensitivity in Adults at Risk of Type 2 Diabetes35.904
Effect of a weight loss program on body composition and metabolic syndrome markers in obese weight cyclers35.904
Optimal diabetes management during medical weight loss for cardiovascular risk reduction35.904
Analysis of the degree of insulin resistance in post menopausal women by using skin temperature measurements and fasting insulin and fasting glucose levels: a case control study35.904
Prevalence of the metabolic syndrome among a racially/ethnically diverse group of U.S. eighth-grade adolescents and associations with fasting insulin and homeostasis model assessment of insulin resistance levels35.904
Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance35.904
Cardiovascular risk and metabolic syndrome in obese youth enrolled in a multidisciplinary medical weight management program: implications of musculoskeletal pain, cardiorespiratory fitness, and health-related quality of life.35.904
Cardiovascular Risk Reduction and Weight Management at a Hospital-Based Postpartum Preeclampsia Clinic35.904
Anthropometric markers for detection of the metabolic syndrome in adolescents35.904
Impact of hypovitaminosis D on clinical, hormonal and insulin sensitivity parameters in normal body mass index polycystic ovary syndrome women35.904
Cardiovascular risk profile and insulin resistance according body mass index, waist circumference and hypertriglyceridemic waist in adult subjects35.904
Lean mass inversely predicts plasma glucose levels after oral glucose load independent of insulin secretion or insulin sensitivity in glucose intolerance subjects35.904
Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance35.904
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels35.904
Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: effect of weight loss after gastric bypass35.904
Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome35.904
Associations between surrogate measures of insulin resistance and waist circumference, cardiovascular risk and the metabolic syndrome across Hispanic and non-Hispanic white populations35.904
Total testosterone levels are correlated to metabolic syndrome components35.904
Do Differences in Waist Circumference Modify the Relationships Among Body Mass Index, Insulin Resistance, and Related Cardiometabolic Risk Factors in Apparently Healthy Women?35.904
Better association of waist circumference with insulin resistance and some cardiovascular risk factors than body mass index35.904
The frequency of insulin resistance calculated upon the basis of a fasting glucose to insulin ratio and characteristics of insulin resistant women with polycystic ovary syndrome35.904
Body Mass, Total Body Fat Percentage, and Visceral Fat Level Predict Insulin Resistance Better Than Waist Circumference and Body Mass Index in Healthy Young Male Adults in Indonesia35.904
A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics35.904
Cardiovascular Risk Markers in Polycystic Ovary Syndrome (PCOS)35.904
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)35.904
Effect of Weight Management Programs on Cardiometabolic Risk Profile in Overweight Women35.904
Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study35.904
WW International35.511
USA Today31.720
Massachusetts General Hospital31.720
Nucleic Acids Research31.720
Q18675631.720
Journal of Vertebrate Paleontology31.720
Shape Magazine31.720
Administration Science Quarterly31.720
United States Department of Veterans Affairs31.720
Behaviour & Information Technology31.720
Q122753831.720
In Vitro Cellular & Developmental Biology - Animal31.720
Historical Journal of Film, Radio and Television31.720
International Journal of Computer Vision31.720
Journal of Contemporary Religion31.720
Inflammation Research31.720
Nanoscale Research Letters31.720
Yale School of Medicine31.720
Agroecology and Sustainable Food Systems31.720
Molecular Physics31.720
Enterprise Information Systems31.720
Journal of Cardiovascular Magnetic Resonance31.720
Australasian Journal of Philosophy31.720
Philosophical Magazine Letters31.720
Journal of Electronic Materials31.720
Grana31.720
Journal of Management Information Systems31.720
High Pressure Research31.720
Insectes Sociaux31.720
Epi Info31.720
New Political Economy31.720
International Journal of Agricultural Sustainability31.720
Memoirs of the New York Botanical Garden31.720
Applied Spectroscopy Reviews31.720
Critical Reviews in Analytical Chemistry31.720
Journal of the American Society for Mass Spectrometry31.720
EDGAR31.720
The Mariner's Mirror31.720
Mathematics Magazine31.720
Molecular and Cellular Biology31.720
Phosphorus, Sulfur, and Silicon and the Related Elements31.720
Rite Aid31.720
World's Poultry Science Journal31.720
International Journal of Acarology31.720
Plasmonics31.720
Caryologia31.720
Journal of Nonlinear Mathematical Physics31.720
International Reviews in Physical Chemistry31.720
Journal of Economic Methodology31.720
Journal of Post Keynesian Economics31.720
Yahoo! Finance31.720
Zoomorphology31.720
Accountability in Research31.720
Acta Applicandae Mathematicae31.720
Advanced Composite Materials31.720
Advances in Applied Clifford Algebras31.720
African Geographical Review31.720
African Identities31.720
African Security Review31.720
Ambix31.720
American Communist History31.720
American Journal of Medical Quality31.720
American Journal of Men's Health31.720
American Journal of Translational Research31.720
Archiv der Mathematik31.720
Archival Science31.720
Argumentation and Advocacy31.720
Asian Affairs31.720
The Washington Post30.903
metabolic syndrome30.903
JAMA Surgery30.903
Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome30.903
Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis30.903
A clinical perspective of obesity, metabolic syndrome and cardiovascular disease30.903
A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys30.903
Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial30.903
Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity30.903
Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome30.903
Addressing the inter-individual variation in response to consumption of plant food bioactives: Towards a better understanding of their role in healthy aging and cardiometabolic risk reduction30.903
Assessment of Insulin Resistance and Impaired Glucose Tolerance in Lean Women with Polycystic Ovary Syndrome30.903
Low-fat versus low-carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk: a randomized control trial.30.903
Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants30.903
Consequences of change in waist circumference on cardiometabolic risk factors over 9 years: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).30.903
Pulse pressure is a strong predictor of cardiovascular risk: Data of the risk factors in impaired glucose tolerance for atherosclerosis and diabetes and the Sofia Metabolic Syndrome studies.30.903
Acetogenic fibers reduce fasting glucose turnover but not peripheral insulin resistance in metabolic syndrome patients30.903
The cutoff values of visceral fat area and waist circumference for identifying subjects at risk for metabolic syndrome in elderly Korean: Ansan Geriatric (AGE) cohort study30.903
Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).30.903
Application of alternative anthropometric measurements to predict metabolic syndrome30.903
Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence30.903
Combined aerobic and resistance exercise is effective for achieving weight loss and reducing cardiovascular risk factors without deteriorating bone health in obese young adults30.903
One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study30.903
Short-term nutritional counseling reduces body mass index, waist circumference, triceps skinfold and triglycerides in women with metabolic syndrome30.903
The mutual effect of pre-pregnancy body mass index, waist circumference and gestational weight gain on obesity-related adverse pregnancy outcomes: A birth cohort study30.903
Associations of pre-pregnancy body mass index and gestational weight gain with pregnancy outcome and postpartum weight retention: a prospective observational cohort study30.903
Can body mass index, waist circumference, waist-hip ratio and waist-height ratio predict the presence of multiple metabolic risk factors in Chinese subjects?30.903
A Cardiovascular Risk Reduction Program for American Indians with Metabolic Syndrome: The Balance Study30.903
Optimal waist circumference cutoff value reflecting insulin resistance as a diagnostic criterion of metabolic syndrome in a nondiabetic Korean population aged 40 years and over: the Chungju Metabolic Disease Cohort (CMC) study30.903
Comparison of body mass index and waist circumference as predictors of cardiometabolic health in a population of young Canadian adults30.903
Impact of birth weight and early infant weight gain on insulin resistance and associated cardiovascular risk factors in adolescence30.903
Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss30.903
Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program30.903
MRI sagittal abdominal diameter is a stronger predictor of metabolic syndrome than visceral fat area or waist circumference in a high-risk vascular cohort30.903
Declining beta-cell function relative to insulin sensitivity with increasing fasting glucose levels in the nondiabetic range in children30.903
A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS).30.903
Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors30.903
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis30.903
Body mass index, waist circumference, and cardiometabolic risk factors in young and middle-aged Chinese women30.903
How well do waist circumference and body mass index reflect body composition in pre-pubertal children?30.903
Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program30.903
Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program30.903
Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health Across the Nation30.903
Assessment and Treatment of Cardiovascular Risk in Prediabetes: Impaired Glucose Tolerance and Impaired Fasting Glucose30.903
Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome30.903
Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study30.903
Adipose Depots, Not Disease-related Factors, Account for Skeletal Muscle Insulin Sensitivity in Established and Treated Rheumatoid Arthritis30.903
Is waist circumference a better predictor of blood pressure, insulin resistance and blood lipids than body mass index in young Chilean adults?30.903
Optimal cutoff values of waist circumference and the discriminatory performance of other anthropometric indices to detect the clustering of cardiovascular risk factors for metabolic syndrome in Japanese men and women.30.903
Gestational weight gain and subsequent postpartum weight loss among young, low-income, ethnic minority women30.903
Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.30.903
Synergistic effects of neck circumference and metabolic risk factors on insulin resistance: the Cardiometabolic Risk in Chinese (CRC) study30.903
Low HDL cholesterol is associated with increased atherogenic lipoproteins and insulin resistance in women classified with metabolic syndrome30.903
Effects of grapefruit, grapefruit juice and water preloads on energy balance, weight loss, body composition, and cardiometabolic risk in free-living obese adults30.903
Statin Therapy Worsens Insulin Sensitivity in Women With Polycystic Ovary Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study30.903
Pancreatic Fat Is Associated With Metabolic Syndrome and Visceral Fat but Not Beta-Cell Function or Body Mass Index in Pediatric Obesity30.903
Statins: cardiovascular risk reduction in percutaneous coronary intervention-basic and clinical evidence of hyperacute use of statins.30.903
Differential impact of impaired fasting glucose versus impaired glucose tolerance on cardiometabolic risk factors in multi-ethnic overweight/obese children30.903
The influence of calcium supplement on body composition, weight loss and insulin resistance in obese adults receiving low calorie diet.30.903
Associations of gestational weight gain with maternal body mass index, waist circumference, and blood pressure measured 16 y after pregnancy: the Avon Longitudinal Study of Parents and Children (ALSPAC)30.903
Preventing Excessive Weight Gain During Pregnancy and Promoting Postpartum Weight Loss: A Pilot Lifestyle Intervention for Overweight and Obese African American Women30.903
Adiponectin Provides Additional Information to Conventional Cardiovascular Risk Factors for Assessing the Risk of Atherosclerosis in Both Genders30.903
Gender differences in diagnostic values of visceral fat area and waist circumference for predicting metabolic syndrome in Koreans30.903
Subclinical atherosclerosis and metabolic risk: role of body mass index and waist circumference.30.903
Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials30.903
Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study.30.903
Which anthropometric measurements including visceral fat, subcutaneous fat, body mass index, and waist circumference could predict the urinary stone composition most?30.903
Is Waist Circumference a Better Predictor of Insulin Resistance Than Body Mass Index in U.S. Adolescents?30.903
Limited Weight Loss or Simply No Weight Gain following Lifestyle-Only Intervention Tends to Redistribute Body Fat, to Decrease Lipid Concentrations, and to Improve Parameters of Insulin Sensitivity in Obese Children30.903
Comparison of Body Mass Index (BMI), Body Adiposity Index (BAI), Waist Circumference (WC), Waist-To-Hip Ratio (WHR) and Waist-To-Height Ratio (WHtR) as Predictors of Cardiovascular Disease Risk Factors in an Adult Population in Singapore30.903
The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females30.903
A case–control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria30.903
How does acupuncture affect insulin sensitivity in women with polycystic ovary syndrome and insulin resistance? Study protocol of a prospective pilot study30.903
Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome30.903
Effect of Ramadan fasting on metabolic markers, body composition, and dietary intake in Emiratis of Ajman (UAE) with metabolic syndrome30.903
Increased gut hormones and insulin sensitivity index following a 3-d intervention with a barley kernel-based product: a randomised cross-over study in healthy middle-aged subjects30.903
Correlations of Insulin Resistance and Serum Testosterone Levels with LH:FSH Ratio and Oxidative Stress in Women with Functional Ovarian Hyperandrogenism30.903
Cardio-metabolic risk screening among adolescents: understanding the utility of body mass index, waist circumference and waist to height ratio30.903
Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study30.903
A qualitative study exploring why adults with intellectual disabilities and obesity want to lose weight and views of their carers30.903
Cardiometabolic Risk Profiles and Carotid Atherosclerosis in Individuals With Prediabetes Identified by Fasting Glucose, Postchallenge Glucose, and Hemoglobin A1c Criteria30.903
Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome30.903
Associations of maternal prepregnancy body mass index and gestational weight gain with adult offspring cardiometabolic risk factors: the Jerusalem Perinatal Family Follow-up Study30.903
Estimating the proportion of metabolic health outcomes attributable to obesity: a cross-sectional exploration of body mass index and waist circumference combinations30.903
Clinical Variability in Cardiovascular Disease Risk Factor Screening and Management in Adolescent and Young Adult Women with Polycystic Ovary Syndrome30.903
Associations between metabolic risk factors and body mass index, waist circumference, waist-to-height ratio and waist-to-hip ratio in a Chinese rural population30.903
Intensified screening and treatment of the metabolic syndrome for cardiovascular risk reduction30.903
Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study30.903
IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition30.903
Comparison of the effects of 52 weeks weight loss with either a high-protein or high-carbohydrate diet on body composition and cardiometabolic risk factors in overweight and obese males30.903
Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now?30.903
One-hour post-load plasma glucose levels associated with decreased insulin sensitivity and secretion and early makers of cardiometabolic risk30.903
Excessive gestational weight gain is associated with long-term body fat and weight retention at 7 y postpartum in African American and Dominican mothers with underweight, normal, and overweight prepregnancy BMI30.903
Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events.30.903
Non–HDL Cholesterol Shows Improved Accuracy for Cardiovascular Risk Score Classification Compared to Direct or Calculated LDL Cholesterol in a Dyslipidemic Population30.903
Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease30.903
Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance.30.903
Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose30.903
Waist-to-height ratio, waist circumference, and body mass index as indices of cardiometabolic risk among 36,642 Taiwanese adults30.903
Use of the triglyceride to HDL cholesterol ratio for assessing insulin sensitivity in overweight and obese children in rural Appalachia30.903
Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus30.903
Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk.30.903
Association between Metabolic Syndrome and Menstrual Irregularity in Middle-Aged Korean Women30.903
Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance30.903
Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study30.903
Relationship between waist circumference, visceral fat and metabolic syndrome in a Congolese community: further research is still to be undertaken30.903
Prevalence of Metabolic Syndrome in Psoriasis Patients and its Relation to Disease Duration: A Hospital Based Case-Control Study30.903
Altered Skeletal Muscle Fatty Acid Handling in Subjects with Impaired Glucose Tolerance as Compared to Impaired Fasting Glucose30.903
Impaired Fasting Glucose and Impaired Glucose Tolerance Have Distinct Lipoprotein and Apolipoprotein Changes: The Insulin Resistance Atherosclerosis Study30.903
Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction30.903
Predictors of metabolic syndrome in the Iranian population: waist circumference, body mass index, or waist to hip ratio?30.903
Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes As30.903
Effect of protein source during weight loss on body composition, cardiometabolic risk and physical performance in abdominally obese, older adults: A pilot feeding study30.903
Characteristics of body composition and cardiometabolic risk of Japanese male heavyweight Judo athletes30.903
Eight weeks of supplementation with a multi-ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women30.903
Biochemical Assessment of Bone Health in Working Obese Egyptian Females with Metabolic Syndrome; the Effect of Weight Loss by Natural Dietary Therapies.30.903
Birth Size, Early Life Weight Gain, and Midchildhood Cardiometabolic Health30.903
Identifying adolescent metabolic syndrome using body mass index and waist circumference30.903
Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study.30.903
Translation of the diabetes prevention program lifestyle intervention for promoting postpartum weight loss among low-income women30.903
Developing an electronic clinical decision support system to promote guideline adherence for healthy weight management and cardiovascular risk reduction in children: a progress update30.903
Association of waist circumference, body mass index and conicity index with cardiovascular risk factors in postmenopausal women.30.903
Antipsychotic Drugs Opposite to Metabolic Risk: Neurotransmitters, Neurohormonal and Pharmacogenetic Mechanisms Underlying with Weight Gain and Metabolic Syndrome30.903
Impact of short term consumption of diets high in either non-starch polysaccharides or resistant starch in comparison with moderate weight loss on indices of insulin sensitivity in subjects with metabolic syndrome30.903
Proposed cut-off values of the waist circumference for metabolic syndrome based on visceral fat volume in a Japanese population30.903
Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss30.903
Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome.30.903
Obesity index that better predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio30.903
Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Resear30.903
Strength Training Prevents Hyperinsulinemia, Insulin Resistance, and Inflammation Independent of Weight Loss in Fructose-Fed Animals30.903
Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference30.903
Application of receiver operating characteristic curve in the assessment of the value of body mass index, waist circumference and percentage of body fat in the Diagnosis of Polycystic Ovary Syndrome in childbearing women30.903
Systematic review of clinical studies related to pork intake and metabolic syndrome or its components30.903
Low-grade chronic inflammation in the relationship between insulin sensitivity and cardiovascular disease (RISC) population: associations with insulin resistance and cardiometabolic risk profile30.903
Lower dipeptidyl peptidase-4 following exercise training plus weight loss is related to increased insulin sensitivity in adults with metabolic syndrome30.903
Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index30.903
From weight loss to weight gain: appetite changes in major depressive disorder as a mirror into brain-environment interactions30.903
Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome30.903
Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects30.903
Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1).30.903
Waist circumference cutoff points to predict obesity, metabolic syndrome, and cardiovascular risk in Turkish adults30.903
Type 2 diabetes family histories, body composition and fasting glucose levels: a cross-section analysis in healthy sedentary male and female30.903
Impact of surgical and nonsurgical weight loss on diabetes resolution and cardiovascular risk reduction30.903
Korean red ginseng improves glucose control in subjects with impaired fasting glucose, impaired glucose tolerance, or newly diagnosed type 2 diabetes mellitus.30.903
Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia30.903
Association of PPARG Pro12Ala polymorphism with insulin sensitivity and body mass index in patients with polycystic ovary syndrome30.903
Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk--a review of the literature30.903
Evaluation of glycaemic status in young people with clinical insulin resistance; fasting glucose, fasting insulin or an oral glucose tolerance test?30.903
Low total testosterone levels are associated with the metabolic syndrome in elderly men: the role of body weight, lipids, insulin resistance, and inflammation; the Ikaria study30.903
Adiponectin/(FBG × FIns) as a predictor of insulin sensitivity and metabolic syndrome in patients with polycystic ovary syndrome30.903
Change in body mass index, weight, and hot flashes: a longitudinal analysis from the midlife women's health study30.903
Correlation between Body Mass Index and Waist Circumference in Patients with Metabolic Syndrome30.903
Impact of weight loss on waist circumference and the components of the metabolic syndrome.30.903
Utility of the waist-to-height ratio, waist circumference and body mass index in the screening of metabolic syndrome in adult patients with type 1 diabetes mellitus30.903
Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial30.903
Association of body mass index, waist circumference, and metabolic syndrome with serum cystatin C in a Chinese population30.903
Additive utility of family history and waist circumference to body mass index in childhood for predicting metabolic syndrome in adulthood30.903
Occurrence of Diabetes Mellitus in Obese Nondiabetic Patients, with Correlative Analysis of Visceral Fat, Fasting Insulin, and Insulin Resistance: A 3-year Follow-up Study (Mysore Visceral Adiposity in Diabetes Follow-up Study).30.903
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society30.903
Increased cardiovascular risk factors in breast cancer survivors identified by routine measurements of body composition, resting heart rate and arterial blood pressure30.903
Restorative yoga and metabolic risk factors: The Practicing Restorative Yoga vs. Stretching for the Metabolic Syndrome (PRYSMS) randomized trial30.903
Management of cardiovascular risk associated with insulin resistance, diabetes, and the metabolic syndrome30.903
Cinnamon improves insulin sensitivity and alters the body composition in an animal model of the metabolic syndrome.30.903
Dietary interventions for weight loss and cardiovascular risk reduction in people of African ancestry (blacks): a systematic review30.903
Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome30.903
Using the Androgen Excess–PCOS Society Criteria to Diagnose Polycystic Ovary Syndrome and the Risk of Metabolic Syndrome in Adolescents30.903
GLP‐1 Receptor Agonists: Effects on Cardiovascular Risk Reduction30.903
Pharmacologic therapy for cardiovascular risk reduction in patients with the metabolic syndrome.30.903
Management of fatty liver disease with the metabolic syndrome30.903
Weight Loss and Physical Activity for Disease Prevention in Obese Older Adults: an Important Role for Lifestyle Management30.903
Sleep characteristics and insulin sensitivity in humans30.903
Extremes of weight gain and weight loss with detailed assessments of energy balance: Illustrative case studies and clinical recommendations30.903
Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m230.903
Body Mass Index, Waist Circumference, and the Clustering of Cardiometabolic Risk Factors in Early Childhood30.903
Effectiveness of Popular Weight Loss Diets on Cardiovascular Risk Reduction30.903
Effects of meal frequency on weight loss and body composition: a meta-analysis30.903
Polycystic ovary syndrome and metabolic syndrome30.903
Metabolic Syndrome: Insulin Resistance and Prediabetes30.903
Insulin resistance in pregnant women with and without polycystic ovary syndrome, and measures of body composition in offspring at birth and 3 years of age.30.903
Polycystic ovary syndrome and metabolic syndrome: the worrisome twosome?30.903
Personalized Weight Management Interventions for Cardiovascular Risk Reduction: A Viable Option for African-American Women30.903
Metabolic Syndrome in Prostate Cancer: Impact on Risk and Outcomes30.903
Metabolic syndrome, insulin resistance and other cardiovascular risk factors in university students30.903
Waist-to-height ratio, body mass index and waist circumference for screening paediatric cardio-metabolic risk factors: a meta-analysis30.903
Glucosamine Enhances Body Weight Gain and Reduces Insulin Response in Mice Fed Chow Diet but Mitigates Obesity, Insulin Resistance and Impaired Glucose Tolerance in Mice High-Fat Diet30.903
Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study30.903
Relationships between IGF-1, schizophrenia, and treatment of metabolic syndrome30.903
Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (30.903
Body mass index and waist circumference: relationship to cardiometabolic risk factors in children--Busselton Health Study 2005-2007.30.903
Body mass index and waist circumference predictors of cardiovascular risk in African Americans30.903
The metabolic syndrome in black hypertensive women--waist circumference more strongly related than body mass index30.903
Non-obese (body mass index < 25 kg/m2) Asian Indians with normal waist circumference have high cardiovascular risk30.903
Secular trends of blood pressure, body mass index, lipids and fasting glucose among children and adolescents in Turkey30.903
Correlation of the effects of dexamethasone administration on urinary 17-ketosteroid and serum androgen levels in patients with hirsutism30.903
Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome30.903
Associations between body mass index, cardiorespiratory fitness, metabolic syndrome, and impaired fasting glucose in young, urban native american women30.903
Body composition and common carotid artery remodeling in a healthy population30.903
Prevalence of undiagnosed diabetes, impaired glucose tolerance, and impaired fasting glucose among Maori in Te Wai o Rona: Diabetes Prevention Strategy30.903
Association of Sleep Deprivation With Reduction in Insulin Sensitivity as Assessed by the Hyperglycemic Clamp Technique in Adolescents30.903
Pre-teen insulin resistance predicts weight gain, impaired fasting glucose, and type 2 diabetes at age 18-19 y: a 10-y prospective study of black and white girls30.903
Determining the optimal cutoff points for waist circumference and body mass index for identification of metabolic abnormalities and metabolic syndrome in urban Thai population30.903
Metabolic Syndrome, Adiponectin, and Cardiovascular Risk in Spain (The Segovia Study): Impact of Consensus Societies Criteria30.903
Low muscle mass is associated with metabolic syndrome only in nonobese young adults: the Korea National Health and Nutrition Examination Survey 2008-201030.903
Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.30.903
A genome scan for fasting insulin and fasting glucose identifies a quantitative trait locus on chromosome 17p: the insulin resistance atherosclerosis study (IRAS) family study30.903
A Larger Body Mass Index is Associated with Increased Atherogenic Dyslipidemia, Insulin Resistance, and Low-Grade Inflammation in Individuals with Metabolic Syndrome30.903
Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention30.903
Could "a body shape index" and "waist to height ratio" predict insulin resistance and metabolic syndrome in polycystic ovary syndrome?30.903
INSULIN RESISTANCE ASSOCIATED WITH METABOLIC SYNDROME AS AN INDICATOR OF CARDIOVASCULAR RISK30.903
Effect of feeding a weight loss food beyond a caloric restriction period on body composition and resistance to weight gain in dogs30.903
Effect of feeding a weight loss food beyond a caloric restriction period on body composition and resistance to weight gain in cats30.903
Effects of a weight loss program on body composition and the metabolic profile in obese postmenopausal women displaying various obesity phenotypes: a MONET group study30.903
Diet-Induced Weight Loss Reduces DNA Damage and Cardiometabolic Risk Factors in Overweight/Obese Women with Polycystic Ovary Syndrome.30.903
Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype30.903
Effect of HCV on fasting glucose, fasting insulin and peripheral insulin resistance in first 5 years of infection30.903
Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability30.903
The discriminative ability of waist circumference, body mass index and waist-to-hip ratio in identifying metabolic syndrome: Variations by age, sex and race30.903
Associations of maternal prepregnancy body mass index and gestational weight gain with cardio-metabolic risk factors in adolescent offspring: a prospective cohort study.30.903
Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome30.903
Social determinants of common metabolic risk factors (high blood pressure, high blood sugar, high body mass index and high waist-hip ratio) of major non-communicable diseases in South Asia region: a systematic review protocol.30.903
Adrenal androgen excess and body mass index in polycystic ovary syndrome30.903
Adrenal androgen excess and body mass index in polycystic ovary syndrome30.903
Waist-to-height ratio is better than body mass index and waist circumference as a screening criterion for metabolic syndrome in Han Chinese adults30.903
Metabolic syndrome and insulin resistance in Thai women with polycystic ovary syndrome30.903
Insulin Resistance, Metabolic Syndrome, and Polycystic Ovary Syndrome in Obese Youth30.903
Body mass index and waist circumference are better predictors of insulin resistance than total body fat percentage in middle-aged and elderly Taiwanese30.903
A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome30.903
Effect of telmisartan on selected adipokines, insulin sensitivity, and substrate utilization during insulin-stimulated conditions in patients with metabolic syndrome and impaired fasting glucose.30.903
Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome30.903
Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency30.903
Waist circumference, waist to hip ratio, and body mass index in the diagnosis of metabolic syndrome in Nigerian subjects30.903
Definition of new cut-offs of BMI and waist circumference based on body composition and insulin resistance: differences between children, adolescents and adults30.903
Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes30.903
Waist circumference below metabolic syndrome harmonizing criteria is associated with increased cardiovascular risk30.903
Apolipoprotein B, non‐HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk30.903
Comparison among body mass index (BMI), waist circumference (WC), and percent body fat (%BF) as anthropometric markers for the clustering of metabolic risk factors in Japanese30.903
Effects of a community-based weight loss program, jointly established by local government and university faculty, on weight loss and metabolic syndrome components: the Sodegaura Weight Management Study30.903
Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L).30.903
Body mass index can similarly predict the presence of multiple cardiovascular risk factors in middle-aged Japanese subjects as waist circumference30.903
Relationship of body mass index, waist circumference and cardiovascular risk factors in Chinese adult30.903
Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters30.903
Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome30.903
The Body Mass Index and Waist Circumference as Predictors Of Body Composition in Post CSCI Wheelchair Rugby Players (Preliminary Investigations).30.903
High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance.30.903
Leptin concentrations in patients with polycystic ovary syndrome before and after met-formin treatment depending on insulin resistance, body mass index and androgen con-centrations--introductory report30.903
Association of body mass index and insulin resistance with metabolic syndrome in Brazilian children.30.903
The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome30.903
Optimal waist circumference for prediction of metabolic syndrome in young Korean women with polycystic ovary syndrome.30.903
Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study30.903
Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome30.903
Study on the body mass index and waist circumference of aged with clustering of other cardiovascular risk factors30.903
Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation30.903
Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome30.903
Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study30.903
Role of waist circumference in the diagnosis of metabolic syndrome and assessment of cardiovascular risk in shift workers30.903
The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction30.903
Body mass index status is effective in identifying metabolic syndrome components and insulin resistance in Pacific Island teenagers living in New Zealand30.903
A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance30.903
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical mode30.903
Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance30.903
The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults30.903
Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.30.903
Frequency of soup intake is inversely associated with body mass index, waist circumference, and waist-to-hip ratio, but not with other metabolic risk factors in Japanese men.30.903
Association between waist-to-height ratio and metabolic risk factors in Korean adults with normal body mass index and waist circumference30.903
Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance30.903
Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study30.903
Body Mass Index, Waist Circumference, and Waist-to-Height Ratio as Predictors of Cardiometabolic Risk in Childhood Obesity Depending on Pubertal Development30.903
The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes30.903
Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels30.903
Prevalence of the metabolic syndrome and its correlation with the cardiovascular health status in stroke- and ischemic heart disease-free Ecuadorian natives/mestizos aged ≥40 years living in Atahualpa: A population-based study30.903
Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijian Melanesians with impaired glucose tolerance or impaired fasting glucose30.903
Weight loss after Swedish Adjustable Gastric Banding: relationships to insulin resistance and metabolic syndrome30.903
Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content30.903
Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study.30.903
Associations of plasma glucose levels and traits of metabolic syndrome with carotid intima media thickness in nondiabetic elderly subjects: are they mediated by insulin resistance?30.903
Relative impact of insulin resistance and obesity on cardiovascular risk factors in polycystic ovary syndrome30.903
The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients30.903
Increased mean glucose levels in patients with polycystic ovary syndrome and hyperandrogenemia as determined by continuous glucose monitoring30.903
Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?30.903
Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study30.903
Meal replacement based on Human Ration modulates metabolic risk factors during body weight loss: a randomized controlled trial30.903
Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome30.903
Comparison of waist circumference versus body mass index in diagnosing metabolic syndrome and identifying apparently healthy subjects at increased risk of cardiovascular disease30.903
Low intensity endurance exercise targeted for lipid oxidation improves body composition and insulin sensitivity in patients with the metabolic syndrome30.903
Fasting insulin sensitivity and post-oral glucose hyperinsulinaemia related to cardiovascular risk factors in adolescents with precocious pubarche.30.903
Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom30.903
Study on the metabolic health risks of body mass index and waist circumference30.903
Skin tags are more closely related to fasting insulin than fasting glucose levels.30.903
Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose30.903
A comparative evaluation of waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index as indicators of impaired glucose tolerance and as risk factors for type-2 diabetes mellitus30.903
Effects of weight loss in obese subjects with normal fasting plasma glucose or impaired glucose tolerance on insulin release and insulin resistance according to a minimal model analysis30.903
Assessment of impaired glucose tolerance prevalence with hemoglobin A1c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study30.903
Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome30.903
Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?30.903
Effect of dynamic strength training on insulin sensitivity in men with insulin resistance30.903
DELIGHT (Delay of impaired glucose tolerance by a healthy lifestyle trial) – A Feasibility Study on Implementing a Program of Sustainable Diabetes Prevention in German Companies30.903
A prospective study on the prevalence of metabolic syndrome among healthy french families: two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-alpha) are revealed in the offspring of parents with metabolic syndrome30.903
Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents30.903
Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population30.903
The Adjusted Effect of Maternal Body Mass Index, Energy and Macronutrient Intakes during Pregnancy, and Gestational Weight Gain on Body Composition of Full-Term Neonates30.903
Insulin Resistance can be Easily Estimated by Body Mass Index and Waist Circumference in a General Japanese Population30.903
Criteria of waist circumference according to computed tomography-measured visceral fat area and the clustering of cardiovascular risk factors30.903
Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity30.903
Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: An observational study30.903
Cardiovascular risk markers in polycystic ovary syndrome in women with and without insulin resistance30.903
Association between circulating endogenous androgens and insulin sensitivity changes with exercise training in midlife women30.903
A unique rodent model of cardiometabolic risk associated with the metabolic syndrome and polycystic ovary syndrome.30.903
Body mass index and waist circumference associate to a comparable degree with insulin resistance and related metabolic abnormalities in South Asian women and men30.903
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study30.903
Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance30.903
High-normal fasting glucose levels are associated with increased prevalence of impaired glucose tolerance in obese children30.903
Homeostasis model assessment of insulin resistance*body mass index interactions at ages 9 to 10 years predict metabolic syndrome risk factor aggregate score at ages 18 to 19 years: a 10-year prospective study of black and white girls30.903
Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance30.903
Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity30.903
Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study30.903
Gender differences between hypocretin/orexin knockout and wild type mice: age, body weight, body composition, metabolic markers, leptin and insulin resistance30.903
Waist circumference alone predicts insulin resistance as good as the metabolic syndrome in elderly women.30.903
Metabolic syndrome and insulin resistance significantly correlate with body mass index30.903
Elevated fasting glucose levels within normal range are associated with an increased risk of metabolic syndrome in older women30.903
Downregulation of genes involved in NFkappaB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin sensitivity in individuals with the metabolic syndrome: the GENOBIN study.30.903
Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study30.903
Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence30.903
Body mass index, waist circumference, and cardiovascular risk factors in adolescents30.903
Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated ldl cholesterol or by decreased hdl cholesterol?: response to Drexel et al.30.903
Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome30.903
Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose especially when they are obese: the ADDITION Netherlands study30.903
Miglitol, α-glycosidase inhibitor, reduces visceral fat accumulation and cardiovascular risk factors in subjects with the metabolic syndrome: a randomized comparable study30.903
Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucose30.903
Waist‐to‐Height Ratio and Body Mass Index as Indicators of Cardiovascular Risk in Youth30.903
The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome30.903
Pioneer study: PPARgamma activation results in overall improvement of clinical and metabolic markers associated with insulin resistance independent of long-term glucose control30.903
The deleterious effects of physical inactivity on elements of insulin resistance and metabolic syndrome in Central Africans at high cardiovascular risk30.903
Short- and long-term relationships of serum ghrelin with changes in body composition and the metabolic syndrome in prepubescent obese children following two different weight loss programmes30.903
Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age?30.903
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects30.903
Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose30.903
Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study30.903
The metabolic inter-relationships between changes in waist circumference, triglycerides, insulin sensitivity and small, dense low-density lipoprotein particles with acute weight loss in clinically obese children and adolescents.30.903
The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome30.903
Dietary energy density is associated with body mass index and waist circumference, but not with other metabolic risk factors, in free-living young Japanese women30.903
Impaired glucose tolerance, impaired fasting glucose and cardiovascular risk30.903
Cardiovascular Risk Assessment Based on Combined Body Mass Index and Waist Circumference in Korean Adults30.903
Rapid Weight Loss vs. Slow Weight Loss: Which is More Effective on Body Composition and Metabolic Risk Factors?30.903
Association between gestational weight gain according to prepregnancy body mass index and short postpartum weight retention in postpartum women30.903
Dietary Intake of Protein from Different Sources and Weight Regain, Changes in Body Composition and Cardiometabolic Risk Factors after Weight Loss: The DIOGenes Study30.903
Waist-to-height ratio is an appropriate index for identifying cardiometabolic risk in Chinese individuals with normal body mass index and waist circumference30.903
Comparison of body mass index, waist circumference, and waist-to-height ratio for predicting the clustering of cardiometabolic risk factors by age in Japanese workers--Japan Epidemiology Collaboration on Occupational Health study.30.903
Preoperative weight loss with glucagon-like peptide-1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis.30.903
Advantages of group treatment and structured exercise in promoting short-term weight loss and cardiovascular risk reduction in adults with central obesity30.903
Medical weight loss versus bariatric surgery: Does method affect body composition and weight maintenance after 15% reduction in body weight?30.903
Second trimester insulin resistance, early pregnancy body mass index and gestational weight gain30.903
Recovery of insulin sensitivity and optimal body composition after rapid weight loss in obese dogs fed a high-protein medium-carbohydrate diet30.903
Priorities and Preferences for Weight Management and Cardiovascular Risk Reduction in Primary Care30.903
A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction30.903
Normal vs. high-protein weight loss diets in men: effects on body composition and indices of metabolic syndrome30.903
Effects of breakfast eating and eating frequency on body mass index and weight loss outcomes in adults enrolled in an obesity treatment program30.903
Prenatal weight gain and postpartum weight loss patterns in adolescents30.903
Insurance coverage and incentives for weight loss among adults with metabolic syndrome30.903
Re: Associations of maternal prepregnancy body mass index and gestational weight gain with cardio-metabolic risk factors in adolescent offspring:a prospective cohort study30.903
Authors' reply re: Associations of maternal prepregnancy body mass index and gestational weight gain with cardio-metabolic risk factors in adolescent offspring: a prospective cohort study.30.903
Reply to comment on: waist-to-height ratio, body mass index and waist circumference for screening pediatric cardio-metabolic risk factors: a meta-analysis.30.903
Comment on: waist-to-height ratio, body mass index and waist circumference for screening paediatric cardio-metabolic risk factors: a meta-analysis30.903
Diagnostic performance of Body Mass Index, Waist Circumference and the Waist-to-Height Ratio for identifying cardiometabolic risk in Scottish pre-adolescents.30.903
Do more specific plans help you lose weight? Examining the relationship between plan specificity, weight loss goals, and plan content in the context of a weight management programme.30.903
Waist Circumference and Cardiometabolic Risk: a Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes As30.903
Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss30.903
Short-term effects of a non-dieting lifestyle intervention program on weight management, fitness, metabolic risk, and psychological well-being in obese premenopausal females with the metabolic syndrome.30.903
Association of Waist Circumference and Body Fat Weight with Insulin Resistance in Male Subjects with Normal Body Mass Index and Normal Glucose Tolerance30.903
Effects of diet-induced weight gain and turnout to pasture on insulin sensitivity in moderately insulin resistant horses30.903
Effects of rapid or slow weight loss on body composition and metabolic risk factors in obese postmenopausal women. A pilot study30.903
Weight management issues and strategies for people with high cardiovascular risk undertaking an Australian weight loss program: A focus group study30.903
Early insulin resistance predicts weight gain and waist circumference increase in first-episode psychosis--A one year follow-up study30.903
A preliminary investigation into whether early intervention can improve weight loss among those initially non-responsive to an internet-based behavioral program30.903
Work stress, weight gain and weight loss: evidence for bidirectional effects of job strain on body mass index in the Whitehall II study30.903
The effect of live weight gain and live weight loss on body composition of Merino wethers: chemical composition of the noncarcass organs and the empty body30.903
Effect of Dietary Weight Loss on Menstrual Regularity in Obese Young Adult Women with Polycystic Ovary Syndrome30.903
A comparison of skinfold thickness, body mass index, bioelectrical impedance analysis and dual-energy X-ray absorptiometry in assessing body composition in obese subjects before and after weight loss30.903
Effect of high-protein or normal-protein diet on weight loss, body composition, hormone, and metabolic profile in southern Brazilian women with polycystic ovary syndrome: a randomized study.30.903
Association between gestational weight gain according to body mass index and postpartum weight in a large cohort of Danish women30.903
The effect of live weight gain and live weight loss on body composition of merino wethers: noncarcass organs30.903
The effect of live weight gain and live weight loss on body composition of merino wethers: chemical composition of the dissected components30.903
The effect of live weight gain and live weight loss on body composition of Merino wethers: dissected muscle, fat, and bone30.903
Rapid weight loss with a high-protein low-energy diet allows the recovery of ideal body composition and insulin sensitivity in obese dogs30.903
The discriminatory performance of body mass index, waist circumference, waist-to-hip ratio and waist-to-height ratio for detection of metabolic syndrome and their optimal cutoffs among Iranian adults30.903
Effect of weight loss on insulin sensitivity and cardiovascular risk factors in glucose tolerant and intolerant obese subjects30.903
Effect of the Mediterranean diet with and without weight loss on cardiovascular risk factors in men with the metabolic syndrome.30.903
Smoking cessation‐related weight gain—beneficial effects on muscle mass, strength and bone health30.903
Psychosocial factors and perspectives on weight gain and barriers to weight loss among adolescents enrolled in obesity treatment30.903
A randomized controlled trial to prevent excessive gestational weight gain and promote postpartum weight loss in overweight and obese women: Health In Pregnancy and Postpartum (HIPP).30.903
Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation30.903
Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction30.903
Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation.30.903
U-shaped association of sleep duration with metabolic syndrome and insulin resistance in patients with type 2 diabetes: The Fukuoka Diabetes Registry30.903
Body mass index, waist circumference, and waist-to-height ratio for prediction of multiple metabolic risk factors in Chinese elderly population30.903
Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.30.903
Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE).30.903
Association of abdominal fat distribution by computed tomography with body mass index and metabolic syndrome in Chinese elders30.903
Effects of a Cardiovascular Risk Reduction Intervention With Psychobehavioral Strategies for Korean Adults With Type 2 Diabetes and Metabolic Syndrome30.903
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder30.903
Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance30.903
Female offspring birth weight is associated with Body Mass Index, waist circumference and metabolic syndrome in Latin American women at 10-years postpartum30.903
Provision of healthy school meals does not affect the metabolic syndrome score in 8-11-year-old children, but reduces cardiometabolic risk markers despite increasing waist circumference30.903
Menstrual Cycle Alterations during Adolescence: Early Expression of Metabolic Syndrome and Polycystic Ovary Syndrome30.903
Influence of Aerobic Training and Detraining on Serum BDNF, Insulin Resistance, and Metabolic Risk Factors in Middle-Aged Men Diagnosed With Metabolic Syndrome30.903
Predictive utility of blood pressure, waist circumference and body mass index for metabolic syndrome in patients with schizophrenia in Singapore.30.903
The effects of exercise training on abdominal visceral fat, body composition, and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: the HERITAGE family study30.903
Insulin Resistance and Lipid Accumulation Product in Corelation to Body Mass Index in Women with Polycystic Ovary Syndrome30.903
Serum total sialic acid, a reputed cardiovascular risk factor, and its relationship to lipids, plasma fasting insulin, blood pressure and body mass index in normal individuals30.903
Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome30.903
Different modalities of exercise to reduce visceral fat mass and cardiovascular risk in metabolic syndrome: the RESOLVE randomized trial30.903
Cis-9, trans-11 and trans-10, cis-12 CLA mixture does not change body composition, induces insulin resistance and increases serum HDL cholesterol level in rats.30.903
Lifestyle modifications supported by regional health nurses lowered insulin resistance, oxidative stress and central blood pressure in subjects with metabolic syndrome30.903
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.30.903
Longitudinal Examination of Links Between Risk Factors for the Metabolic Syndrome and Both Age and Fasting Glucose Levels in Nondiabetic Subjects30.903
The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial30.903
Effects of n-3 pufas on fasting plasma glucose and insulin resistance in patients with impaired fasting glucose or impaired glucose tolerance30.903
Increased levels of serum granzyme-B is associated with insulin resistance and increased cardiovascular risk in adolescent polycystic ovary syndrome patients30.903
Diagnostic Accuracies of Glycated Hemoglobin, Fructosamine, and Homeostasis Model Assessment of Insulin Resistance in Predicting Impaired Fasting Glucose, Impaired Glucose Tolerance, or New Onset Diabetes After Transplantation.30.903
Mean platelet volume in a patient with male hypogonadotropic hypogonadism: the relationship between low testosterone, metabolic syndrome, impaired fasting glucose and cardiovascular risk30.903
Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients30.903
Associations between visceral fat and liver fat with insulin sensitivity and metabolic risk in obese adolescents30.903
Obesity Modifies the Association between Serum 25-Hydroxyvitamin D and Insulin Resistance in Korean General Population without Increased Fasting Glucose Levels30.903
Increased acyl ghrelin but decreased total ghrelin and unacyl ghrelin in Chinese Han people with impaired fasting glucose combined with impaired glucose tolerance30.903
Prepregnancy Body Mass Index and Prenatal Fasting Glucose Are Effective Predictors of Early Postpartum Metabolic Syndrome in Spanish Mothers with Gestational Diabetes30.903
Visceral adipose tissue measured by DXA correlates with measurement by CT and is associated with cardiometabolic risk factors in children30.903
Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial30.903
A Randomized Intervention Trial of 24-wk Dairy Consumption on Waist Circumference, Blood Pressure, and Fasting Blood Sugar and Lipids in Japanese Men with Metabolic Syndrome30.903
Relationship between maternal fasting glucose levels at 4–12 gestational weeks and offspring growth and development in early infancy30.903
Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial30.903
Liver enzymes but not free fatty acid levels predict markers of insulin sensitivity in overweight and obese, nondiabetic adults30.903
Development and a pilot test of an internet-based cardiovascular risk reduction program for Korean male workers with metabolic syndrome.30.903
The absence of insulin resistance in metabolic syndrome definition leads to underdiagnosing of metabolic risk in obese patients.30.903
Visceral fat area, waist circumference and metabolic risk factors in abdominally obese Chinese adults30.903
Relationship between waist circumference and body mass index and metabolic syndrome related traits among middle school students in Beijing30.903
Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome30.903
Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk30.903
Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome30.903
Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study.30.903
Endothelial function in young women with polycystic ovary syndrome (PCOS): Implications of body mass index (BMI) and insulin resistance.30.903
Insulin resistance, as expressed by HOMA-R, is strongly determined by waist circumference or body mass index among Japanese working men30.903
The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome30.903
Heart rate recovery is more strongly associated with the metabolic syndrome, waist circumference, and insulin sensitivity in women than in men among the elderly in the general population.30.903
Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.30.903
The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study30.903
Agreement among insulin sensitivity indexes on the diagnosis of insulin resistance in polycystic ovary syndrome and ovulatory women30.903
Identification of factors differentially associated with isolated impaired fasting glucose and isolated post-load impaired glucose tolerance: the Hong Kong Cardiovascular Risk Factor Study.30.903
Waist circumference and body mass index in Chinese children: cutoff values for predicting cardiovascular risk factors30.903
Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls30.903
The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome30.903
Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency30.903
Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin30.903
Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol30.903
Insulin resistance, body mass index, waist circumference are independent risk factor for high blood pressure30.903
Insulin resistance: the link between impaired glucose tolerance, body mass index and plasma lipids.30.903
Epicardial adipose tissue is associated with visceral fat, metabolic syndrome, and insulin resistance in menopausal women30.903
Metabolic syndrome and visceral fat in women with cardiovascular risk factor30.903
Insulin resistance and β-cell function influence postprandial blood glucose levels in Japanese patients with gestational diabetes mellitus30.903
Relationship between abdominal obesity, platelet blood count and mean platelet volume in patients with metabolic syndrome30.903
Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study).30.903
Blood microRNA profile associates with the levels of serum lipids and metabolites associated with glucose metabolism and insulin resistance and pinpoints pathways underlying metabolic syndrome: the cardiovascular risk in Young Finns Study30.903
Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion30.903
Improvements in body composition, cardiometabolic risk factors and insulin sensitivity with trenbolone in normogonadic rats30.903
Optimal cut points of waist circumference (WC) and visceral fat area (VFA) predicting for metabolic syndrome (MetS) in elderly population in the Korean Longitudinal Study on Health and Aging (KLoSHA).30.903
Effective cut-off values of waist circumference to detect the clustering of cardiovascular risk factors of metabolic syndrome in Japanese men and women30.903
Poor Sleep Quality is Associated with Insulin Resistance in Postmenopausal Women With and Without Metabolic Syndrome30.903
High serum ferritin levels are associated with insulin resistance but not with impaired glucose tolerance in a healthy people population.30.903
A descriptive study of facial acanthosis nigricans and its association with body mass index, waist circumference and insulin resistance using HOMA2 IR.30.903
Insulin sensitivity, body composition and adipose depots following 12 w combined endurance and strength training in dysglycemic and normoglycemic sedentary men.30.903
Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk30.903
Waist circumference, trunk and visceral fat cutoff values for detecting hyperinsulinemia and insulin resistance in children: the Healthy Growth Study30.903
LDL cholesterol was more strongly associated with percent body fat than body mass index and waist circumference in a health screening population30.903
Factors Associated with Visceral Fat Loss in Response to a Multifaceted Weight Loss Intervention30.903
Rubrik30.903
The effects of a novel combination of selenium and probiotic on weight loss, glycemic control and markers of cardio-metabolic risk in women with polycystic ovary syndrome30.903
Waist Circumference Coupled with Either HDL-C or TG Can Be Used as a Diagnostic Marker for Metabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome30.903
Associations of Gestational Weight Gain With Maternal Body Mass Index, Waist Circumference, and Blood Pressure Measured 16 Years After Pregnancy: The Avon Longitudinal Study of Parents and Children30.903
Cardiovascular risk in subjects with high probability of metabolic syndrome and insulin resistance. DESIRE study30.903
Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat30.903
Serum testosterone levels may influence body composition and cardiometabolic health in men with spinal cord injury30.903
A 6-week supplementation with grape pomace to subjects at cardiometabolic risk ameliorates insulin sensitivity, without affecting other metabolic syndrome markers30.903
The effect of a very low calorie diet on insulin sensitivity, beta cell function, insulin clearance, incretin hormone secretion, androgen levels and body composition in obese young women30.903
Body shape indices and cardiometabolic risk in adolescents30.903
The relative contributions of insulin resistance and beta cell failure to the transition from normal to impaired glucose tolerance varies in different ethnic groups30.903
Contribution of antiretroviral therapy, cardiovascular risk factors and constituents of metabolic syndrome to insulin resistance(IR) in HIV30.903
Eight weeks of supplementation with a multi-ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women30.903
Maternal and Fetal Outcomes in Preeclampsia: Interrelations Between Insulin Resistance, Aldosterone, Metabolic Syndrome, and Polycystic Ovary Syndrome30.903
High-Molecular-Weight Adiponectin Is Selectively Reduced in Women With Polycystic Ovary Syndrome Independent of Body Mass Index and Severity of Insulin Resistance30.903
Metabolic Syndrome and Insulin Resistance Syndrome among Infertile Women with Polycystic Ovary Syndrome: A Cross-Sectional Study from Central Vietnam30.903
Ability of Alternative Indices of Insulin Sensitivity to Predict Cardiovascular Risk30.903
Performance of Waist-To-Height Ratio, Waist Circumference, and Body Mass Index in Discriminating Cardio-Metabolic Risk Factors in a Sample of School-Aged Mexican Children30.903
Androgen levels, insulin sensitivity, and early insulin response in women with polycystic ovary syndrome: a long-term follow-up study30.903
Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population30.903
Prevalence and Treatment of Low HDL Cholesterol Among Primary Care Patients With Type 2 Diabetes: An unmet challenge for cardiovascular risk reduction30.903
Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese30.903
Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human Obesity30.903
Predictors of Maternal Weight Gain and Neonatal Body Composition30.903
The Metabolic Effects of Different Weight Loss Diets30.903
Effect of a Unique Web-based Behaviour Change Program on Weight Loss and Cardiovascular Risk Factors30.903
Mechanisms Underlying Postoperative Insulin Resistance and Inflammation30.903
Acupuncture to Treat Insulin Resistance in Women With and Without Polycystic Ovary Syndrome30.903
Macronutrient Relations and Weight Loss in Obese Subjects30.903
A Crossover Trial of Chitosan Oligosaccharide on Post Prandial Glucose Control in Subjects With Normal, IFG and IGT30.903
Comparison of Weight Loss Induced by Bariatric Surgery vs Conventional Treatment30.903
Hormonal Regulation of Postpartum Weight and Presence of Gut Peptides in Human Milk30.903
Body mass index (BMI) and waist circumference (WC) as screening tools for cardiovascular risk factors in Guadeloupean women30.903
The Effects of Strawberries on Blood Cholesterol.30.903
CHRONOtype-adjusted DIET on Weight Loss30.903
Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance30.903
Effect of Stablor on Visceral Fat Loss in Patients With a Metabolic Syndrome30.903
Beneficial Effects of a Polyphenol Enriched Beverage on Type 2 Diabetes Prevention and on Cardiovascular Risk Profile of Men and Women With Insulin Resistance.30.903
Study of Brain Function in Women With Insulin Resistant Polycystic Ovary Syndrome30.903
Association Between Changes in Postpartum Weight and Waist Circumference and Changes in Cardiometabolic Risk Factors Among Women With Recent Gestational Diabetes30.903
Comparison of surgical versus diet-induced weight loss on appetite regulation and metabolic health outcomes30.903
Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome30.903
DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome30.903
Obesity Treatment Using an Internet-delivered Intervention Based on the Diabetes Prevention Program in Mexican Adults30.903
Replacing Refined Carbohydrates With Healthy Fats on Cardio-metabolic Markers30.903
Impact of Structured Physical Activity Education Delivery in Patients With Type 2 Diabetes Mellitus30.903
Effect of Low-calorie Diet on Serum Lipids, Adipokines, Insulin Resistance and Also Body Composition in Women With Metabolic Syndrome30.903
Meal Patterning on Weight Loss With Changes to Body Comp, Muscle and Metabolic Health30.903
Cardiovascular Risk Reduction Associated with Pharmacological Weight Loss: A Meta-Analysis30.903
Ginsenoside Improve Metabolic Syndrome30.903
The Effect of Acupuncture on Insulin Sensitivity Polycystic Ovary Syndrome30.903
Effects of a Bakery Product Enriched With Fibre and L-carnitine on Insulin Resistance in Patients With Metabolic Syndrome30.903
The Effect of Sugar Sweetened and Diet Beverages Consumed as Part of a Weight-Maintenance Diet on Fat Storage30.903
The Effect of Korean Red Ginseng Supplementation on Glucose Control30.903
Coffee and Metabolic Health Outcomes30.903
Acute Effects of Tocotrienols on Insulin Sensitivity and Metabolic Risk Markers in Individuals at Risk for Metabolic Syndrome30.903
Effects of Telemonitoring Service for Obesity Care30.903
STUDY: Effects of Potatoes in a Weight Loss Program30.903
High Versus Normal Protein Diet in Polycystic Ovary Syndrome (PCOS)30.903
Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)30.903
Impact of Diet and/or Exercise-Induced Weight Loss on Cardiovascular Risk Factors30.903
Weight Loss for Uncontrolled Asthma Associated With Elevated BMI30.903
2-5 Intermittent Caloric Restriction for Weight Loss and Insulin Resistance in HIV-Infected Adults With Features of the Metabolic Syndrome30.903
Increased Arterial Stiffness in Prediabetic Subjects Recognized by Hemoglobin A1c with Postprandial Glucose but Not Fasting Glucose Levels.30.903
SAT-228 A Longitudinal Prospective Cohort Study of Fasting Glucose to Insulin Ratio and Fasting Insulin Resistance Index in Normal and Preeclamptic Pregnancies30.903
Effect of Exercise Modality During Weight Loss on Bone Health in Older Adults With Obesity and Cardiovascular Disease or Metabolic Syndrome: A Randomized Controlled Trial30.903
SAT-LB019 Improvement of Visceral Fat and Body Composition Endpoints in Participants on Prescription Thyroid Replacement with a Doctor-Supervised Weight Loss Program30.903
Does Dairy Benefit Bone & Body Composition in Overweight Girls Undergoing a Weight Management Program?30.903
Maternal Hypertriglyceridaemia Study30.903
The RCT of Acupuncture on PCOS Combined With IR30.903
Effectiveness of Four Popular Diet Strategies for Weight Loss and Cardiac Risk Reduction30.903
Correlation of Irisin and Adipokine Levels With Body Mass Index and Risk Factors for Metabolic Syndrome in Hispanic Children30.903
The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)30.903
Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity30.903
Acetylcarnitine and Insulin Sensitivity30.903
Testosterone Effects on Men With the Metabolic Syndrome30.903
Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome30.903
Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.30.903
Sympathetic Activity in Individuals With the Metabolic Syndrome: Benefits of Lifestyle Interventions30.903
Study of Serum Markers for Cardiovascular Risk in Obese Youth and Impact of Lifestyle and Medication Intervention30.903
12 Weeks of Resistance Band Exercise Impacts on Metabolic Syndrome Progression in Postmenopausal Women30.903
An Anti-inflammatory Diet Effect on Metabolic, Inflammatory and Immune Status of Obese Younger Adults30.903
Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight)30.903
The Sleep Lengthening and Metabolic Health, Body Composition, Energy Balance and Cardiovascular Risk Study30.903
Study of the Relationship Between Body Composition, Insulin Resistance and HDL Levels30.903
Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults30.903
Waist circumference and sagittal diameter reflect total body fat better than visceral fat in older men and women. The Health, Aging and Body Composition Study30.903
Fat oxidation, body composition and insulin sensitivity in diabetic and normoglycaemic obese adults 5 years after weight loss30.903
[Can higher level of HDL cholesterol augment cardiovascular disease prevention? The combination statins-nicotinic acid increases the level of HDL and reduces the level of LDL cholesterol]30.903
Body mass index and waist circumference: association with cardiovascular risk factors30.903
Visceral fat mass as a marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome30.903
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome30.903
Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome30.903
Comparison of two doses of metformin (2.5 and 1.5 g/day) for the treatment of polycystic ovary syndrome and their effect on body mass index and waist circumference30.903
Metabolic syndrome does not increase the risk of conversion of impaired glucose tolerance to diabetes in Asian Indians--Result of Indian diabetes prevention programme30.903
Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes As30.903
The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation30.903
Evaluation of metabolic syndrome risk in Korean premenopausal women: not waist circumference but visceral fat30.903
Cardiovascular risk reduction via increasing HDL cholesterol: the promise of the dal-OUTCOMES Trial30.903
Study of impaired glucose tolerance, dyslipidemia, metabolic syndrome, and cardiovascular risk in a south Indian population30.903
Predictive value of body mass index and waist circumference for metabolic syndrome in 6-12-year-olds30.903
Waist circumference is better associated with high density lipoprotein (HDL-c) than with body mass index (BMI) in adults with metabolic syndrome30.903
A recommended approach to evaluate cardiovascular risk and to prevent cardiovascular diseases and type 2 diabetes mellitus in women with polycystic ovary syndrome30.903
Strength training improves insulin sensitivity and plasma lipid levels without altering body composition in overweight and obese subjects30.903
Polycystic ovary syndrome, metabolic syndrome, cardiovascular risk and the role of insulin sensitizing agents30.903
Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered30.903
Even moderate weight loss can lower your heart risk. Research shows that strength training and aerobic exercise can help sedentary seniors decrease their risk for insulin resistance30.903
Assessing and Managing Metabolic Syndrome and Cardiovascular Risk in Midlife Women30.903
Body composition, metabolic syndrome and insulin resistance in type 1 diabetes mellitus30.903
Optimal cut-off levels of body mass index and waist circumference in relation to each component of metabolic syndrome (MetS) and the number of MetS component30.903
Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance30.903
Body Mass Index or Waist Circumference: Which Is the Better Predictor for Hypertension and Dyslipidemia in Overweight/Obese Children and Adolescents? Association of Cardiovascular Risk Related to Body Mass Index or Waist Circumference30.903
Superiority of waist circumference and body mass index in cardiovascular risk assessment in hypertensive patients with coronary heart disease30.903
Different waist circumference measurements and prediction of cardiovascular risk factors and metabolic syndrome in children30.903
Waist circumference is a better predictor than body mass index of insulin resistance in type 2 diabetes30.903
Association of smoking status, insulin resistance, body mass index, and metabolic syndrome in workers: A 1-year follow-up study30.903
METFORMIN-SUSTAINED WEIGHT LOSS AND REDUCED ANDROID FAT TISSUE AT 12 MONTHS IN EMPOWIR (ENHANCE THE METABOLIC PROFILE OF WOMEN WITH INSULIN RESISTANCE): A DOUBLE BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF NORMOGLYCEMIC WOMEN WITH MIDLIFE WEIGHT30.903
Body Mass Index, Waist Circumference, Visceral Adiposity, and Cardiometabolic Risk Profile30.903
Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients30.903
Impact of Visceral Fat Measurements and a Weight Loss Support Web System on Visceral Fat Loss in a Workplace Setting: Insights from a JVALUE2 (Japanese Study of Visceral Adiposity and Lifestyle Information; Utilization and Evaluation)30.903
Correction to: Seyyed Abootorabi et al., The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial30.903
The effect of increasing tertiles of waist circumference on cardio-metabolic risk, adipokines and biomarkers of inflammation and oxidative stress in nascent metabolic syndrome30.903
Epicardial Fat, Metabolic Dysregulation, and Cardiovascular Risk: Putting Things Together30.903
Low HDL cholesterol but not high LDL cholesterol is independently associated with subclinical coronary atherosclerosis in healthy octogenarians30.903
Serum granzyme-B, insulin resistance, metabolic syndrome and cardiovascular risk: statistical validity for risk assessment30.903
Smoking is associated with impaired glucose regulation and a decrease in insulin sensitivity and the disposition index in first-degree relatives of type 2 diabetes subjects independently of the presence of metabolic syndrome30.903
Sagittal abdominal diameter resembles waist circumference as a surrogate marker of insulin resistance in adolescents-Brazilian Metabolic Syndrome Study30.903
Comparison of Lipid Accumulation Product Index with Body Mass Index and Waist Circumference as a Predictor of Metabolic Syndrome in Indian Population30.903
Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients30.903
Follicular hyperandrogenism and insulin resistance in polycystic ovary syndrome patients with normal circulating testosterone levels30.903
Why Weight? An Analytic Review of Obesity Management, Diabetes Prevention, and Cardiovascular Risk Reduction30.903
Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system30.903
[The cut-off points of body mass index and waist circumference for predicting metabolic risk factors in Chinese adults]30.903
[Effect of the DiabetIMSS program on cardiovascular risk, blood pressure and HDL cholesterol in patients with metabolic syndrome]30.903
Impaired fasting glucose levels in overweight or obese subjects for screening of type 2 diabetes in Korea30.903
Body mass index trajectories in early childhood in relation to cardiometabolic risk profile and body composition at 5 years of age30.903
Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention30.903
Effect of Lifestyle Coaching Including Telemonitoring and Telecoaching on Gestational Weight Gain and Postnatal Weight Loss: A Systematic Review30.903
Comparative Abilities of Body Mass Index, Waist Circumference, Abdominal Volume Index, Body Adiposity Index, and Conicity Index as Predictive Screening Tools for Metabolic Syndrome among Apparently Healthy Ghanaian Adults30.903
Large body mass index and waist circumference are associated with high blood pressure and impaired fasting glucose in young Chinese men30.903
The Association between Adult Weight Gain and Insulin Resistance at Middle Age: Mediation by Visceral Fat and Liver Fat30.903
Body Composition, Serum Concentrations of Androgens and Insulin Resistance in Different Polycystic Ovary Syndrome Phenotypes30.903
Height predict incident non-alcoholic fatty liver disease among general adult population in Tianjin, China, independent of body mass index, waist circumference, waist-to-height ratio, and metabolic syndrome30.903
Cardiovascular Risk Reduction in the Workplace With CAMMPUS (Cardiovascular Assessment and Medication Management by Pharmacists at the UBC Site)30.903
Increase of body mass index and waist circumference predicts development of metabolic syndrome criteria in apparently healthy individuals with 2 and 5 years follow-up30.903
Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome30.903
Waist circumference percentile curves as a screening tool to predict cardiovascular risk factors and metabolic syndrome risk in Brazilian children30.903
Association of Albuminuria With Intraglomerular Hydrostatic Pressure and Insulin Resistance in Subjects With Impaired Fasting Glucose and/or Impaired Glucose Tolerance30.903
Insulin resistance: a key therapeutic target for cardiovascular risk reduction in obese patients?30.903
Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies30.903
A prospective pilot study of the effect of acupuncture on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance30.903
Body Composition, Metabolic Characteristics, and Insulin Resistance in Obese and Nonobese Women with Polycystic Ovary Syndrome30.903
Long-term Weight Loss Maintenance in the Continuation of a Randomized Diabetes Prevention Translational Study: The Healthy Living Partnerships to Prevent Diabetes (HELP PD) Continuation Trial30.903
Optimal Fasting Plasma Glucose Levels and Hemoglobin A1c Levels for Screening of Prediabetes and Diabetes According to 2-Hour Plasma Glucose Criterion in a High-Risk Population: The Korean Diabetes Prevention Study30.903
Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes - a cross-sectional study30.903
Circulating ANGPTL8 Is Associated with the Presence of Metabolic Syndrome and Insulin Resistance in Polycystic Ovary Syndrome Young Women30.903
Postpartum weight retention in relation to gestational weight gain and pre-pregnancy body mass index: A prospective cohort study in Vietnam30.903
Reassessing the risk of kidney organ donation: Researchers are taking a closer look at the long-term health risks that living kidney donors may face to refine the informed consent process and improve follow-up care30.903
Insulin sensitivity improvement with exercise training is mediated by body weight loss in subjects with metabolic syndrome30.903
Correlation between Pregnancy Related Weight Gain, Postpartum Weight loss and Obesity: a Prospective Study30.903
Insulin Sensitivity Indices in Patients with Polycystic Ovary Syndrome with Different Body Mass Index Categories30.903
Endocrine characteristics, body mass index and metabolic syndrome in women with polycystic ovary syndrome30.903
The Effect of a Low Glycemic Index Pulse-Based Diet on Insulin Sensitivity, Insulin Resistance, Bone Resorption and Cardiovascular Risk Factors during Bed Rest30.903
Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome30.903
Dietary Protein Intake Associations with Insulin Resistance, BMI, Body Composition and Other Metabolic Markers in Subjects with Prediabetes and Type 2 Diabetes Mellitus (P08-020-19)30.903
SAT-102 Self-efficacy As A Predictor Of Weight Loss In Veterans With Obesity Participating In Medical Weight Management30.903
Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis30.903
Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome30.903
Periodontal Status and High‐Sensitivity C‐Reactive Protein Levels in Polycystic Ovary Syndrome With and Without Medical Treatment30.903
Waist Circumference Rather than Body Mass Index is Better Indicator of Insulin Resistance in Type 2 Diabetes Mellitus in North Indian Population30.903
Strength Training and Insulin Resistance: The Mediating Role of Body Composition30.903
Insurance-Mandated Medical Weight Management Programs in Sleeve Gastrectomy Patients Do Not Improve Postoperative Weight Loss Outcomes at 1 Year30.903
Beyond Asian-Specific Cutoffs: Gender Effects on the Predictability of Body Mass Index, Waist Circumference, and Waist Circumference to Height Ratio on Hemoglobin A1c30.903
Added sugar and sugar-sweetened beverages are associated with increased postpartum weight gain and soluble fiber intake is associated with postpartum weight loss in Hispanic women from Southern California30.903
Serum apelin and resistin levels in patients with impaired fasting glucose, impaired glucose tolerance, Type 2 diabetes and metabolic syndrome30.903
Metformin doses and body mass index: clinical outcomes in insulin resistant polycystic ovary syndrome women30.903
Weight loss during medical weight management does not predict weight loss after bariatric surgery: a retrospective cohort study30.903
A comparison between body mass index and waist circumference for identifying continuous metabolic syndrome risk score components in Iranian school-aged children using a structural equation modeling approach: the CASPIAN-V study30.903
Cardiometabolic health, visceral fat and circulating irisin levels: results from a real-world weight loss study30.903
High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain30.903
Secular changes in mid-adulthood body mass index, waist circumference, and low HDL cholesterol between 1990, 2003, and 2018 in Great Britain30.903
Association of the Brain-derived Neurotrophic Factor Val66Met Polymorphism with Body Mass Index, Fasting Glucose Levels and Lipid Status in Adolescents30.903
Metabolic syndrome in systemic lupus erythematosus was closely related to body mass index, blood pressure, blood sugar, blood lipids, and arthritis30.903
Comment on: Weight loss during medical weight management does not predict weight loss after bariatric surgery: a retrospective cohort study30.903
Individual Response Variation in the Effects of Weight Loss and Exercise on Insulin Sensitivity and Cardiometabolic Risk in Older Adults30.903
Associations between pre-pregnancy body mass index and gestational weight gain with pregnancy outcomes in women with polycystic ovary syndrome30.903
The effects of financial incentives on diabetes prevention program attendance and weight loss among low-income patients: the We Can Prevent Diabetes cluster-randomized controlled trial30.903
Body mass index rather than the phenotype impacts precocious ultrasound cardiovascular risk markers in polycystic ovary syndrome30.903
A Nutrition Counseling Curriculum to Address Cardiovascular Risk Reduction for Internal Medicine Residents30.903
Increased visceral fat accumulation modifies the effect of insulin resistance on arterial stiffness and hypertension risk30.903
Metabolic Signatures of Gestational Weight Gain and Postpartum Weight Loss in a Lifestyle Intervention Study of Overweight and Obese Women30.903
Direct and indirect effects of poor sleep quality on body mass index and waist circumference in a female population-based study in Southern Brazil30.903
tirzepatide30.903
Novel Combination of Exercise and Carbohydrate Restriction for Metabolic Health30.903
Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose30.903
Total Joint Arthroplasty (TJA) Weight Loss Study30.903
Postpartum Weight Loss for Women at Elevated Cardiovascular Risk30.903
Impact of 11-oxygenated Androgens on Metabolic Dysfunction of Women With Polycystic Ovary Syndrome30.903
A Pilot Study Comparing Megestrol Acetate Concentrated Suspension (MA-CS) to Megestrol Acetate Oral Suspension (MA-OS) on Weight Gain and Body Composition in Patients with HIV-Associated Unintended Weight Loss (UWL).30.903
1124 Identifying Predictors of Weight Loss for Patients Enrolled in an Intensive Medical Weight Management Program30.903
Weight Loss and Changes in Body Composition after a Six-Week Diet/Strength Training Program30.903
If insulin resistance lowering therapy is effective in polycystic ovary syndrome patients with androgen excess, why to start with various symptom-oriented treatment forms?30.903
Effects of resveratrol nanocapsules on the quantitative insulin sensitivity check index in insulin resistance: a study on metabolic syndrome induce mice30.903
Dissecting Androgen Excess and Metabolic Dysfunction for an Integrated Systems Approach to Polycystic Ovary Syndrome Through the Assessment of Detailed Phenome and Metabolome Data30.903
The relationship between serum irisin levels with cardiovascular risk factors and insulin resistance parameters in patients with metabolic syndrome30.903
Polycystic ovary syndrome; The role of androgen excess in disease pathogenesis and metabolic dysfunction30.903
From weight management via diabetes control to cardiovascular risk reduction30.903
Metabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable?30.903
Effects of Combined Exercise on Body composition, Glycosylated Hemoglobin, and Heart Rate at Rest in Blood Sugar in women with Impaired Glucose Tolerance30.903
Go Leaner30.903
Harbor30.903
major depressive disorder24.502
polyendocrine metabolic ovarian syndrome24.502
medical guideline24.502
weight cycling24.502
anti-obesity medication24.502
bariatric medicine24.502
continuous glucose monitor24.502
The China Study24.502
glucose intolerance24.502
type 2 diabetes24.502